T-lymphocyte Lymphoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors (NCT06911710) | Tianjin Medical University General Hospital | 2024-11-09 |
Track T-lymphocyte Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.